Related Experiment Video
Updated: Sep 8, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary Artery Pulsatility Index: A Novel Marker for Risk Assessment and Prognosis in Pediatric Idiopathic
Emine Gülşah Torun1, Nevin Özdemiroğlu2, Denizhan Bağrul3
1Department of Pediatric Cardiology, Turkish Ministry of Health, Ankara Bilkent City Hospital, 1604th Street, No: 9, Cankaya/Ankara, 06800, Turkey. drgtorun@gmail.com.
Insights
The pulmonary artery pulsatility index (PAPi) effectively stratifies risk in pediatric idiopathic pulmonary arterial hypertension (IPAH). Lower PAPi values predict a higher need for invasive interventions, aiding clinical decision-making.
Area of Science:
- Cardiology
- Pediatric Pulmonology
- Medical Diagnostics
Background:
- Idiopathic pulmonary arterial hypertension (IPAH) in children requires accurate risk stratification.
- The pulmonary artery pulsatility index (PAPi) is a potential non-invasive marker for right heart function.
- Predicting the need for invasive intervention in pediatric IPAH is crucial for timely management.
Purpose of the Study:
- To evaluate the clinical utility of PAPi in risk stratification for pediatric IPAH.
- To assess PAPi's performance in predicting the necessity of invasive interventions due to severe right heart failure.
- To establish PAPi as a prognostic marker in pediatric IPAH management.
Main Methods:
- Retrospective analysis of clinical, echocardiographic, and right heart catheterization data from 24 pediatric IPAH patients.
- Statistical analyses included ROC curve analysis, Kaplan-Meier survival analysis, and Cox regression.
- Correlation analysis with functional status (6MWT, WHO-FC) and biomarkers (NT-proBNP).
Main Results:
- High-risk pediatric IPAH patients exhibited significantly lower PAPi values (p < 0.001).
- A PAPi cutoff of < 3.24 strongly predicted high-risk status (92% sensitivity, 82% specificity).
- Lower PAPi independently predicted increased need for invasive interventions (HR 0.36, p=0.042); PAPi > 3.24 correlated with longer event-free survival (p=0.002).
Conclusions:
- PAPi serves as a reliable prognostic marker for risk stratification in pediatric IPAH.
- Lower PAPi values are associated with a greater likelihood of requiring invasive interventions.
- PAPi can aid clinicians in predicting the need for intervention and guiding treatment decisions in pediatric IPAH.
Abstract:
The pulmonary artery pulsatility index (PAPi), calculated as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/mean right atrial pressure). This study aimed to assess the clinical utility of PAPi in risk stratification for pediatric idiopathic pulmonary arterial hypertension (IPAH) and its performance in predicting the need for invasive intervention due to severe right heart failure. We analyzed clinical, echocardiographic, and right heart catheterization findings of 24 IPAH patients between April 2019 and November 2024. Statistical analyses included ROC curve analysis for PAPi's diagnostic performance, Kaplan-Meier survival analysis, and Cox regression for identifying independent predictors of intervention. The study included 24 patients (mean age 8.2 ± 4.7 years, 66.7% female). Based on pediatric risk classification, 45.8% were lower-risk, and 54.2% were high-risk, with PAPi significantly lower in high-risk patients (p < 0.001). ROC analysis identified PAPi < 3.24 as a strong predictor of high-risk status (sensitivity = 92%, specificity = 82%). PAPi correlated positively with 6MWT (r = 0.802) and TAPSE (r = 0.812) and negatively with WHO-FC (r = - 0.692) and NT-proBNP (r = - 0.713) (p < 0.001). Over 22 ± 15.9 months, 37.5% (n = 9) required invasive interventions for syncope, WHO-FC III/IV symptoms, or right ventricular failure, including atrial septostomy (77.8%), partial ASD closure (11.1%), and reverse Potts shunt (11.1%). Post-intervention, all but one patient improved. Patients requiring intervention had lower PAPi (1.88 ± 0.71 vs. 3.95 ± 1.27, p < 0.001). Kaplan-Meier analysis confirmed PAPi > 3.24 was associated with longer event-free survival (p = 0.002). Cox regression showed higher PAPi independently predicted lower intervention risk (HR 0.36, p = 0.042). In conclusion, this study suggests that PAPi is a reliable prognostic marker for risk stratification and predicting the need for invasive intervention in pediatric IPAH.
Related Concept Videos
Measurement of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pulse
The pulse serves as a clinical...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Blood Pressure

